Brain Inositol Is a Novel Stimulator for Promoting Cryptococcus Penetration of the Blood-Brain Barrier

PLoS Pathogens

Volumn 9, Issue 4, 2013, Pages

  Liu, Tong Bao ^a   Kim, Jong Chul ^b   Wang, Yina ^a,c   Toffaletti, Dena L ^d   Eugenin, Eliseo ^a,e   Perfect, John R ^d   Kim, Kee Jun ^b   Xue, Chaoyang ^a,e  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2, 4 DINITROPHENOL; HERMES ANTIGEN; HYALURONIC ACID; INOSITOL; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CANDIDA ALBICANS; CATABOLISM; CEREBROSPINAL FLUID; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGAL MENINGITIS; FUNGUS GROWTH; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MICROARRAY ANALYSIS; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY; UPREGULATION; VIRULENCE;

ANIMALS; ANTIGENS, CD44; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM INFECTIONS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMANS; HYALURONIC ACID; INOSITOL; MALE; MENINGITIS, CRYPTOCOCCAL; MICE; MICE, INBRED A; MONOSACCHARIDE TRANSPORT PROTEINS; RABBITS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALIA; FILOBASIDIELLA NEOFORMANS;

EID: 84876823618     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003247     Document Type: Article

References (79)

1. Powderly WG, (2000) Cryptococcal Meningitis in HIV-Infected Patients. Curr Infect Dis Rep 2: 352-357.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, et al. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23: 525-530.
3. Casadevall A, Perfect JR (1998) Cryptococcus neoformans. Washington, DC: ASM press.
4. Pukkila-Worley R, Mylonakis E, (2008) Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 9: 551-560.
5. Chayakulkeeree M, Perfect JR, (2006) Cryptococcosis. Infect Dis Clin North Am 20: 507-544, v-vi.
6. Alspaugh JA, Perfect JR, Heitman J, (1997) Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev 11: 3206-3217.
7. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, et al. (2000) Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 30: 47-54.
8. Doering TL, (2009) How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu Rev Microbiol 63: 223-247.
9. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, et al. (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 50: 291-322.
10. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, and Casadevall A (2011) Cryptococcus from human pathogen to model yeast. Washington, DC: ASM press.
11. Xue C, Tada Y, Dong X, Heitman J, (2007) The human fungal pathogen Cryptococcus can complete its sexual cycle during a pathogenic association with plants. Cell Host Microbe 1: 263-273.
12. Luberto C, Toffaletti DL, Wills EA, Tucker SC, Casadevall A, et al. (2001) Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev 15: 201-212.
13. Shea JM, Del Poeta M, (2006) Lipid signaling in pathogenic fungi. Curr Opin Microbiol 9: 352-358.
14. Heung LJ, Kaiser AE, Luberto C, Del Poeta M, (2005) The role and mechanism of diacylglycerol-protein kinase C1 signaling in melanogenesis by Cryptococcus neoformans. J Biol Chem 280: 28547-28555.
15. Gerik KJ, Bhimireddy SR, Ryerse JS, Specht CA, Lodge JK, (2008) PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans. Eukaryot Cell 7: 1685-1698.
16. Barnett JA, (1976) The utilization of sugars by yeasts. Adv Carbohydr Chem Biochem 32: 125-234.
17. Healy ME, Dillavou CL, Taylor GE, (1977) Diagnostic medium containing inositol, urea, and caffeic acid for selective growth of Cryptococcus neoformans. J Clin Microbiol 6: 387-391.
18. Nikawa J, Tsukagoshi Y, Yamashita S, (1991) Isolation and characterization of two distinct myo-inositol transporter genes of Saccharomyces cerevisiae. J Biol Chem 266: 11184-11191.
19. Reynolds TB, (2009) Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. Microbiology 155: 1386-1396.
20. Chen YL, Kauffman S, Reynolds TB, (2008) Candida albicans uses multiple mechanisms to acquire the essential metabolite inositol during infection. Infect Immun 76: 2793-2801.
21. Niederberger C, Graub R, Schweingruber AM, Fankhauser H, Rusu M, et al. (1998) Exogenous inositol and genes responsible for inositol transport are required for mating and sporulation in Schizosaccharomyces pombe. Curr Genet 33: 255-261.
22. Wang Y, Liu TB, Delmas G, Park S, Perlin D, et al. (2011) Two major inositol transporters and their role in cryptococcal virulence. Eukaryot Cell 10: 618-628.
23. Xue C, Liu T, Chen L, Li W, Liu I, et al. (2010) Role of an expanded inositol transporter repertoire in Cryptococcus neoformans sexual reproduction and virulence. mBio 1: e00084-00010.
24. Donahue TF, Henry SA, (1981) Inositol mutants of Saccharomyces cerevisiae: mapping the Ino1 locus and characterizing alleles of the Ino1, Ino2 and Ino4 loci. Genetics 98: 491-503.
25. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, et al. (2004) Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72: 4985-4995.
26. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, et al. (2010) Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 120: 1683-1693.
27. Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, et al. (2002) Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 186: 522-530.
28. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, et al. (2009) Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77: 120-127.
29. Casadevall A, (2010) Cryptococci at the brain gate: break and enter or use a Trojan horse? J Clin Invest 120: 1389-1392.
30. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR, (2000) Urease as a virulence factor in experimental cryptococcosis. Infect Immun 68: 443-448.
31. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, et al. (2004) Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164: 1761-1771.
32. Maruvada R, Zhu L, Pearce D, Zheng Y, Perfect J, et al. (2012) Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol 14: 1544-1553.
33. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, et al. (2001) Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39: 166-175.
34. Stie J, Fox D, (2012) Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology 158: 240-258.
35. Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, et al. (2011) Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3). J Biol Chem 286: 34761-34769.
36. Jong A, Wu CH, Gonzales-Gomez I, Kwon-Chung KJ, Chang YC, et al. (2012) Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 287: 15298-15306.
37. Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, et al. (2008) Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 10: 1313-1326.
38. Fisher SK, Novak JE, Agranoff BW, (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82: 736-754.
39. Isaacks RE, Bender AS, Kim CY, Prieto NM, Norenberg MD, (1994) Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 19: 331-338.
40. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, et al. (2003) Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52: 961-970.
41. Jong A, Wu CH, Prasadarao NV, Kwon-Chung KJ, Chang YC, et al. (2008) Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation. Cell Microbiol 10: 1854-1865.
42. Vincent VL, Klig LS, (1995) Unusual effect of myo-inositol on phospholipid biosynthesis in Cryptococcus neoformans. Microbiology 141 (Pt 8): 1829-1837.
43. Kwon-Chung KJ, Varma A, (2006) Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 6: 574-587.
44. Jong AY, Stins MF, Huang SH, Chen SH, Kim KS, (2001) Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun 69: 4536-4544.
45. Liu Y, Mittal R, Solis NV, Prasadarao NV, Filler SG, (2011) Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog 7: e1002305.
46. Ashizawa N, Yoshida M, Aotsuka T, (2000) An enzymatic assay for myo-inositol in tissue samples. J Biochem Biophys Methods 44: 89-94.
47. Vu K, Weksler B, Romero I, Couraud PO, Gelli A, (2009) Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell 8: 1803-1807.
48. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, et al. (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166: 421-432.
49. Lee A, Toffaletti DL, Tenor J, Soderblom EJ, Thompson JW, et al. (2010) Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitis. Infect Immun 78: 4213-4225.
50. Brown PM, Caradoc-Davies TT, Dickson JM, Cooper GJ, Loomes KM, et al. (2006) Crystal structure of a substrate complex of myo-inositol oxygenase, a di-iron oxygenase with a key role in inositol metabolism. Proc Natl Acad Sci U S A 103: 15032-15037.
51. Mackenzie EA, Klig LS, (2008) Computational modeling and in silico analysis of differential regulation of myo-inositol catabolic enzymes in Cryptococcus neoformans. BMC Mol Biol 9: 88.
52. McCarter JD, Withers SG, (1994) Mechanisms of enzymatic glycoside hydrolysis. Curr Opin Struct Biol 4: 885-892.
53. Jong A, Wu CH, Chen HM, Luo F, Kwon-Chung KJ, et al. (2007) Identification and characterization of CPS1 as a hyaluronic acid synthase contributing to the pathogenesis of Cryptococcus neoformans infection. Eukaryot Cell 6: 1486-1496.
54. Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ, (2006) CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun 74: 3930-3938.
55. Long M, Huang SH, Wu CH, Shackleford GM, Jong A, (2012) Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells. J Biomed Sci 19: 19.
56. Jin JH, Seyfang A, (2003) High-affinity myo-inositol transport in Candida albicans: substrate specificity and pharmacology. Microbiology 149: 3371-3381.
57. Pukkila-Worley R, Gerrald QD, Kraus PR, Boily MJ, Davis MJ, et al. (2005) Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell 4: 190-201.
58. Kim KS, (2001) Escherichia coli translocation at the blood-brain barrier. Infect Immun 69: 5217-5222.
59. Dietzman DE, Fischer GW, Schoenknecht FD, (1974) Neonatal Escherichia coli septicemia-bacterial counts in blood. J Pediatr 85: 128-130.
60. Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A, (2011) Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog 7: e1002047.
61. Jain N, Guerrero A, Fries BC, (2006) Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans. FEMS Yeast Res 6: 480-488.
62. Sabiiti W, May RC, (2012) Capsule independent uptake of the fungal pathogen Cryptococcus neoformans into brain microvascular endothelial cells. PLoS One 7: e35455.
63. Moyrand F, Janbon G, (2004) UGD1, encoding the Cryptococcus neoformans UDP-glucose dehydrogenase, is essential for growth at 37 degrees C and for capsule biosynthesis. Eukaryot Cell 3: 1601-1608.
64. Griffith CL, Klutts JS, Zhang L, Levery SB, Doering TL, (2004) UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J Biol Chem 279: 51669-51676.
65. Weigel PH, (2002) Functional characteristics and catalytic mechanisms of the bacterial hyaluronan synthases. IUBMB Life 54: 201-211.
66. Nelson DE, Koukoumanos M, Bohnert HJ, (1999) Myo-inositol-dependent sodium uptake in ice plant. Plant Physiol 119: 165-172.
67. Glendinning JI, Nelson NM, Bernays EA, (2000) How do inositol and glucose modulate feeding in Manduca sexta caterpillars? J Exp Biol 203: 1299-1315.
68. Nelson N, Bernays E, (1998) Inositol in two host plants of Manduca sexta. Ehtomologia Experimentalis et Applicata 88: 189-193.
69. Waterman SR, Hacham M, Hu G, Zhu X, Park YD, et al. (2007) Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J Clin Invest 117: 794-802.
70. Yao H, Kim K, Duan M, Hayashi T, Guo M, et al. (2011) Cocaine hijacks sigma1 receptor to initiate induction of activated leukocyte cell adhesion molecule: implication for increased monocyte adhesion and migration in the CNS. J Neurosci 31: 5942-5955.
71. Kim J-C, Crary B, Chang YC, Kwon-Chung KJ, Kim KJ, (2012) Cryptococcus neoformans activates RhoGTPases followed by PKC, FAK and ezrin to enhance traversal across the blood-brain barrier. J Biol Chem 287: 36147-57 doi:jbc.M112.389676.
72. Perfect JR (1999) Rabbit model of cryptococcal meningitis. In: Zak O, Sande, M A., editor. Handbook of animal models of infection. London: Academic Press, Inc. pp. 721-776.
73. Perfect JR, Lang SD, Durack DT, (1980) Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101: 177-194.
74. Nielsen K, Cox GM, Litvintseva AP, Mylonakis E, Malliaris SD, et al. (2005) Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection. Infect Immun 73: 4922-4933.
75. Kraus PR, Boily MJ, Giles SS, Stajich JE, Allen A, et al. (2004) Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray. Eukaryot Cell 3: 1249-1260.
76. Ko YJ, Yu YM, Kim GB, Lee GW, Maeng PJ, et al. (2009) Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways. Eukaryot Cell 8: 1197-1217.
77. Han GS, Wu WI, Carman GM, (2006) The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme. J Biol Chem 281: 9210-9218.
78. Kim KJ, Chung JW, Kim KS, (2005) 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J Biol Chem 280: 1360-1368.
79. Eugenin EA, Clements JE, Zink MC, Berman JW, (2011) Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31: 9456-9465.